Angela Hildreth
Angela is experienced strategically, financially and operationally in developing and commercialising pharmaceutical and consumer healthcare products. Angela has been FD/COO of Futura Medical Plc (listed on AIM) since 2018…
Dr John Richards
John read Chemistry at St John’s College Oxford prior to completing a DPhil in Peptide Chemistry also at Oxford. Following his doctorate, John carried out post-doctoral research at the…
Dr Ian Gilham
Ian is an experienced CEO and Chairman of life sciences companies. He is currently Chairman of Genedrive plc (listed on AIM) and Cytox Limited. From 2014-2021 he was Chairman…
Derek Smith
Derek has over 20 years experience of sales, marketing and management within the diagnostic, medical devices and therapeutics sectors. He holds a degree in Medical Laboratory Science from the…
Alastair Fleming
Alastair has held senior executive positions in the life science industry. He has a broad business knowledge over a career spanning 39 years, within several different sectors, including Medical…
Dr Rob Quinn
Rob brings a wealth of both scientific and financial experience to Aptamer Group, with particular expertise in publicly listed biotechnology and pharmaceutical companies. From 2019-2021 he was…
Dr David Bunka
David holds a Ph.D. in Molecular Biology and has spent nearly 20 years developing nucleic acid aptamers against a wide variety of targets including small molecules (antibiotics, food contaminants,…
Dr Arron Tolley
Arron holds a Ph.D. in Molecular Biology and Biophysics and a B.Sc. in Molecular Medicine from the University of Leeds. Arron has several years’ experience raising aptamers against complex…